P
PDS Biotechnology Corporation (PDSB)
NCM – Real vaqt narxi. Valyuta: USD
1.06
-0.03 (-3.18%)
Bozor ochiq: May 13, 2026, 10:25 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.06
-0.03 (-3.18%)
Bozor ochiq: May 13, 2026, 10:25 AM EDT
PDS Biotechnology Corporation — bu klinik bosqichdagi biofarmatsevtika kompaniyasi bo'lib, Qo'shma Shtatlarda saratonni maqsadli immunoterapiyasi bo'yicha mahsulotlar portfelini ishlab chiqmoqda. Kompaniyaning asosiy mahsuloti nomzodi PDS0101, Versamune HPV bo'lib, u bosh va bo'yin, bachadon bo'yni, anal, vaginal, vulvar va jinsiy olat saratonini davolash uchun II bosqich klinik sinovdan o'tmoqda. Kompaniya shuningdek, preklinik sinovlarda bo'lgan turli mahsulot nomzodlarini ishlab chiqmoqda, jumladan, o'tkir miyeloid leykemiya, prostata va ko'krak bezi saratonini davolash uchun o'smaga bog'liq va immunologik faol T-hujayra retseptor gamma alternativ o'qish ramkali oqsildan foydalanadigan tadqiqot immunoterapiyasi PDS0102; va tuxumdon, ko'krak bezi, kolorektal va o'pka saratonini davolash uchun PDS0103. Bundan tashqari, kompaniya PDS01ADC ni ishlab chiqmoqda, bu yangi tadqiqot Interleykin 12 bilan birlashtirilgan antitel-dorilagi konjugati bo'lib, u o'smaga yo'naltirilgan interleykin 12 immunotsitokini bo'lib, u o'sma mikro-muhitida T-hujayralarning ko'payishini, kuchini va uzoq umrini oshiradi. Kompaniya Milliy Sog'liqni Saqlash Instituti, Merck Eprova AG, AQSh Sog'liqni Saqlash va Inson Xizmatlari Departamenti, Jorjiya Tadqiqot Jamg'armasi va MSD International GmbH bilan litsenziyalash va hamkorlik shartnomalariga ega. PDS Biotechnology Corporation 2005 yilda tashkil etilgan va Prinston, Nyu-Jersi shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Frank K. Bedu-Addo Ph.D. | President, CEO & Director |
| Dr. Gregory L. Conn Ph.D. | Chief Scientific Officer |
| Dr. Kirk V. Shepard M.D. | Chief Medical Officer |
| Mr. Lars Robert Boesgaard M.B.A. | Principal Financial & Accounting Officer and CFO |
| Mr. Spencer Brown J.D. | Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer |
| Mr. Stephan Toutain M.B.A., M.S. |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-01 | 8-K | ef20072168_8k.htm |
| 2026-04-28 | 10-K/A | ef20071357_10ka.htm |
| 2026-04-24 | S-3/A | ny20071147x1_s3a.htm |
| 2026-04-24 | 8-K | ef20071434_8k.htm |
| 2026-04-15 | 8-K | ef20070560_8k.htm |
| 2026-03-30 | 10-K | ef20060644_10k.htm |
| 2026-03-03 | 8-K | ef20067044_8k.htm |
| 2026-02-23 | 8-K | ef20066317_8k.htm |
| 2026-02-20 | 8-K | ef20066174_8k.htm |
| 2026-01-28 | 8-K | ef20064069_8k.htm |
| Chief Operating Officer |
| Ms. Janetta Trochimiuk | Controller |